60
Participants
Start Date
May 31, 2013
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Vibrissae trimming
Patients will have oxymetazoline administered prior to assessment of outcome measures to ensure minimal impact of erectile mucosal tissue on measurement.
Application of oxymetazoline
Afrin will be administered to minimize the impact of erectile mucosal tissue on obstruction.
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER